期刊文献+

红霉素A9(O-叔丁基二甲基硅)肟的合成 被引量:3

Synthesis of Erythromycin A9(O-t-butyldimethylsilyl) Oxime
在线阅读 下载PDF
导出
摘要 以红霉素A与盐酸羟胺反应得到红霉素A肟(EMAO,Ⅰ),再以叔丁基二甲基氯硅烷(TBDMSCl)与Ⅰ进行硅醚化反应制备红霉素A9(O-叔丁基二甲基硅)肟(TBDS—EMAO,Ⅱ)。研究了硅醚化反应的溶剂化作用,有机碱催化作用,Z、E异构体的活性。实验结果表明,含孤电子对的极性非质子溶剂及相应的有机碱催化剂有助于在含有多个羟基的Ⅰ中进行肟羟基的选择性硅醚化反应。硅醚化反应以THF为溶剂,室温,反应物浓度c(Ⅰ)=0.27—0.53mol/L,硅醚化试剂用量n(TBDMSCl):n(Ⅰ)=1.4:1,有机碱用量n(Et3N):n(Ⅰ)=2.2:1时,收率可达97%。用HPLC分析了产品及相应的异构体,Z-Ⅱ反应活性较E-Ⅱ高。用IR、1HNMR、13CNMR、EIMS以及元素分析确证了相关物质的结构。 Erythromycin A reacted with hydroxylamine hydrochloride to form erythromycin A oxime (EMAO, Ⅰ ). Then Ⅰ was silylated with tert-butyldimethylsilyl chloride (TBDMSC1) to give erythromycin A 9 (O-t-butyldimethylsilyl) oxime ( TBDS - EMAO, Ⅱ ). The effect of solvent, catalyst, and reactivity of silylating agent toward the Z/E isomers of Ⅱ were studied. The experiment reveals that selective silylation reaction toward Ⅰ containg multiple hydroxyl groups is promoted by polar aprotic solvent and organic base catalyst with unshared pair of electrons. The silylation reaction can be easily performed in THF at room temperature with c( Ⅰ ) =0. 27 -0.53 mol/L,n(TBDMSCl):n( Ⅰ ) = 1.4 :1 and n(Et3N):n( Ⅰ ) =2. 2:1 to give Ⅱ in 97% yield. The product and coresponding Z/E isomers were analysized by HPLC, showing that the reactivity of Z- Ⅱ is higher than E- Ⅱ. Their structures were identified by IR, 1HNMR, 13CNMR, EI - MS and elementary analysis.
出处 《精细化工》 EI CAS CSCD 北大核心 2007年第2期162-165,共4页 Fine Chemicals
基金 河北省教育厅科研基金资助项目(Z2005210) 河北师范大学博士基金(L2003B12)
关键词 红霉素A9(O-叔丁基二甲基硅)肟 硅醚化 叔丁基二甲基氯硅烷 erythromycin A9 (O-t-butyldimethylsilyl) oxime silylation t-butyldimethylsilyl chloride
  • 相关文献

参考文献10

  • 1Ghilsoo Nam,Tae Won Kang,Jung Hyu Shinc,et al.Design,synthesis,and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives[J].Bioorganic & Medicinal Chemistry Letters,2006 (16):569-572.
  • 2Gasc J C,Gouin d'Ambrières,S G Lutz A,et al.New ether oxime derivatives of erythromycin A.A structure-activity relationship study[J].Journal of Antibiotics 1991,44,313-30.
  • 3Watanabe Y,Adahci T.Chemcal modification of erythromycin Ⅷ.A new effective route to clarithromycin(6-O-methylerythromycin A)[J].Heterocycles,1990,31(12),2121-2124.
  • 4Clark R F,Ma Z K,Wang S,et al.Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivative[J].Bioorganic & Medicinal Chemistry Letter,2000(10)815-819.
  • 5孙京国,梁建华,邓志华,姚国伟.克拉霉素的合成进展[J].有机化学,2002,22(12):951-963. 被引量:29
  • 6梁建华,孙京国,邓志华,姚国伟.红霉素肟的醚化反应活性研究[J].精细化工,2003,20(5):310-313. 被引量:2
  • 7Allevi P,Longo A,Anastasia M.A new convenient transformation of erythromycin A into clarithromycin[J].J Med Chem,1999,7(12):2749-2752.
  • 8Ku Yiyin.9-Oximesilyl erythromycin A derivatives[P].US:5 837 829,1998-11-17.
  • 9孙京国,姚国伟.红霉素肟及相关化合物的高效液相色谱分析[J].分析化学,2003,31(9):1089-1092. 被引量:11
  • 10Robert R Wilkening,Maplewood N J.Process for the preparation of 9-deoxo-9(Z)-hydroxy-iminoerythromycin A[P].US:5 912 331,1999-06-15.

二级参考文献91

  • 1马舒冰.红霉素衍生物的半合成及构效关系[J].国外医药(抗生素分册),1996,17(1):33-37. 被引量:5
  • 2Sun Jingguo(孙京国) Liang Jianhua(梁建华) Deng Zhihua(志华) Yao Guowei(姚国伟).Chinese Journal of Organic Chemistry(有机化学),2002,22(12):951-963.
  • 3Sun Jingguo(孙京国 ).Academic Conference of China Association for Science and Technology in 2001(2001中国科技年会)[M].,2001.1524.
  • 4Kurath P,Jones P H,Egan R S,et al. Acid degradation of erythromycin A and erythvmycin B[J]. Experienta,1971,27(4) :362.
  • 5Watanabe Y,Morimoto S, Omura S. Novel erythrmnycin compounds[P]. US:4 331 803,1982.
  • 6Robinson W S. Erythromycin derivatives and compositions and use for inhibiting virus replication and disease[ P]. EP:0 254 534 A2,1987.
  • 7Gasc J C,DAmbrieres S G,Lutz A,et al.New ether oxime derivatives of erythromycin[J]. J Antibiot,1991,44(3) :313 -360.
  • 8Watanabe Y,Morimoto S,Goi M,et al. Method for selective methylation of erythromycin A derivatives[ P]. US :4 672 109,1987.
  • 9Morimoto S, Matsunaga T,Adachi T,et al.Erythromycin A derivatives and method for the preparation of the same[ P]. EP:0272 110,1987.
  • 10Watanabe Y,Morimoto S,Adachi T,et al. Chemical modification of erythromycins[J]. J Antibiot,1993,46(4) :647 -660.

共引文献36

同被引文献27

  • 1ERNESTO B, DULCE M M, FRANCISCO P,et al. Preparation of clarithromycin, selective 6-O-methylation of the novel erythromycin A 9-O-( 2-pyrimidyl ) oxime [ J ]. Tetrahedron Letters ,2007,48 ( 8 ) : 1321-1324.
  • 2ALLEVI P, LONGO A, Anastasia M. A new convenient transformation of erythromycin A into clarithromycin [ J ]. J Med Chem, 1999,7 ( 12 ) :2749-2752.
  • 3DILEK D, VIKTORYA A, CANAN B. Modeling the selective methylation in the synthesis of clarithromycin [ J ]. J Chem Soc Perkin Trans 2, 2002:6704575.
  • 4CLARK R F,MA Z K,WANG S,et al. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivative [ J ]. Bioor Med Chem Lett,2000,10(8) : 815-819.
  • 5KU Y Y. 9-oximesilyl erythromycin A derivatives[ P]. US: 5 837 829,1998-11-17.
  • 6STATE FOOD and DRUG ADMINISTRATION. Guidance Principle of Medicine Research Technical (药物研究技术指导原则)[M].Beijing: Chin Med Science and Technology Press,2006:9-13.
  • 7SUN J G,YAO G W, OU Y X. The comparative Process for the Preparation of 9-Oxime Erythromycin A [ J ]. Journal of Beijing Institue of Technology, 2004,13 ( 1 ) :76-79.
  • 8MURALI K M,SURESH B M,KETAN D V,et al.Process for preparing erythromycin derivative,such as rox-ithromycin,from the corresponding oxime:US,6 051 695[P].2000-04-18.
  • 9DJOKIC S,KOBREHEL G,LAZAREVSKI G,et al.Erythromycin series,part Ⅱ.ring expansion of erythromycin a oxime by the Beckmann rearrangement[J].J.Chem.Soc.,Perkin Trans.,1986,1(2):1 881-1 890.
  • 10MORIMOTO S,TAKAHASH1 Y,WATANABE Y,et al.Chemical modificatin of erythromycin Ⅰ.synthesis and antibacterial activity of 6-O-methylerythromycins A[J].J.Antibiot.,1984,37(2):187-189.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部